Merck Company Stock Today

MRK Stock  USD 126.96  0.19  0.15%   


24 of 100


Odds Of Distress

Less than 1

Very Small
Merck is selling for 126.96 as of the 3rd of March 2024. This is a -0.15 percent down since the beginning of the trading day. The stock's last reported lowest price was 126.42. Merck has a very small chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. Equity ratings for Merck Company are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of February 2024 and ending today, the 3rd of March 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
13th of January 1978
Health Care
Merck Co., Inc. operates as a healthcare company worldwide. Merck Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. Merck operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. The company has 2.53 B outstanding shares of which 16.82 M shares are now shorted by investors with about 2.2 days to cover. More on Merck Company

Moving together with Merck Stock

  0.65ESPR Esperion Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against Merck Stock

  0.93VALN Valneva SE ADR Report 28th of March 2024 PairCorr
  0.84DYAI Dyadic International Report 3rd of April 2024 PairCorr
  0.58SLS Sellas Life Sciences Report 21st of March 2024 PairCorr
  0.52PFE Pfizer Inc Fiscal Quarter End 31st of March 2024 PairCorr
  0.51MBIO Mustang Bio Report 3rd of April 2024 PairCorr

Merck Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Merck's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Merck or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Merck's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Merck's managers, analysts, and investors.
Environment Score
Governance Score
Social Score
ChairmanKenneth Frazier
Thematic Ideas
(View all Themes)
SEC FilingsMerck Security & Exchange Commission EDGAR Reports
Old Names[Merck & Company Inc, Marka S.A., Merck & Company Inc, Merck & Company Inc]
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, DAX Index, Dow Jones Industrial, SP 500 Index, SP 100 Index, SP 100, Dow Jones Composite, NYSE US 100, ARCA Pharmaceutical, ARCA Institutional, ARCA Major Markets, DAX Price, HDAX Performance, BETTERINVESTING 100 INDEX, BTRINVSTNG 100 INDEX, HDAX Price, Compulsion, Giant Impact, Robots And Drones, Health Care, Pharmaceuticals, Drug Manufacturers—General, Healthcare (View all Sectors)
Excise Tax ActivitiesAnimal TestingCatholic
Average Analyst Recommendation
Analysts covering Merck report their recommendations after researching Merck's financial statements, talking to executives and customers, or listening in on Merck's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Merck Company. The Merck consensus assessment is calculated by taking the average forecast from all of the analysts covering Merck.
Financial Strength
Based on the analysis of Merck's profitability, liquidity, and operating efficiency, Merck Company is performing exceptionally good at this time. It has a great probability to report excellent financial results in April. Financial strength of Merck Company is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Shares Diluted2.5 B2.5 B
Fairly Down
Slightly volatile
Weighted Shares2.5 B2.5 B
Fairly Down
Slightly volatile
Return on Assets0.00310.003
Fairly Up
Pretty Stable
Net Cash Flow from Operations13.7 B13 B
Sufficiently Up
Slightly volatile
Current Liabilities26 B25.7 B
Fairly Up
Slightly volatile
Total Liabilities70.4 B69 B
Fairly Up
Slightly volatile
Gross Margin0.770.732
Sufficiently Up
Slightly volatile
Total Debt34.5 B35.1 B
Fairly Down
Slightly volatile
Asset Turnover0.570.565
Slightly Up
Slightly volatile
Current Assets29.7 B32.2 B
Significantly Down
Slightly volatile
Total Assets112.4 B106.7 B
Notably Up
Very volatile
Merck's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Merck's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Merck's bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of Merck's outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Merck's financial leverage. It provides some insight into what part of Merck's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Merck's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Merck deploys its capital and how much of that capital is borrowed.
Merck cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 1.37 B in debt with debt to equity (D/E) ratio of 0.68, which is OK given its current industry classification. Merck Company has a current ratio of 1.43, which is typical for the industry and considered as normal. Debt can assist Merck until it has trouble settling it off, either with new capital or with free cash flow. So, Merck's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Merck Company sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Merck to invest in growth at high rates of return. When we think about Merck's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

13.68 Billion
Merck Company (MRK) is traded on New York Stock Exchange in USA. It is located in 126 East Lincoln Avenue, Rahway, NJ 07065, United States and employs 70,000 people. Merck is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a total capitalization of 321.54 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Merck's market, we take the total number of its shares issued and multiply it by Merck's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Merck Company runs under Pharmaceuticals sector within Health Care industry. The entity has 2.53 B outstanding shares of which 16.82 M shares are now shorted by investors with about 2.2 days to cover. Merck Company has about 12.69 B in cash with 17.19 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.44.
Check Merck Probability Of Bankruptcy
Ownership Allocation
Merck Company maintains a total of two billion five hundred thirty-two million six hundred fourty thousand outstanding shares. The majority of Merck outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Merck Company to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Merck Company. Please pay attention to any change in the institutional holdings of Merck as this could imply that something significant has changed or about to change at the company. Please note that no matter how much assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Merck Ownership Details

Merck Stock Price Odds Analysis

Proceeding from a normal probability distribution, the odds of Merck jumping above the current price in 90 days from now is about 13.43%. The Merck Company probability density function shows the probability of Merck stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Merck has a beta of 0.5518. This indicates as returns on the market go up, Merck average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Merck Company will be expected to be much smaller as well. Additionally, the company has an alpha of 0.2617, implying that it can generate a 0.26 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 126.96HorizonTargetOdds Above 126.96
86.48%90 days
Based on a normal probability distribution, the odds of Merck to move above the current price in 90 days from now is about 13.43 (This Merck Company probability density function shows the probability of Merck Stock to fall within a particular range of prices over 90 days) .

Merck Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Merck that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Merck's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Merck's value.
InstituionRecorded OnShares
Norges Bank2023-12-31
28.5 M
Bank Of New York Mellon Corp2023-09-30
25 M
Jpmorgan Chase & Co2023-09-30
23 M
Legal & General Group Plc2023-09-30
20.1 M
Deutsche Bank Ag2023-09-30
19.3 M
Amvescap Plc.2023-09-30
17.7 M
Nuveen Asset Management, Llc2023-09-30
16.7 M
Ameriprise Financial Inc2023-09-30
16.6 M
Wells Fargo & Co2023-09-30
16.4 M
Vanguard Group Inc2023-09-30
243.5 M
Blackrock Inc2023-09-30
202.9 M
View Merck Diagnostics

Merck Historical Income Statement

Merck Company Income Statement is one of the three primary financial statements used for reporting Merck's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Merck Company revenue and expense. Merck Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Merck's Research and Development Expense is quite stable as compared to the past year. Income Tax Expense is expected to rise to about 1.7 B this year, although the value of Gross Profit will most likely fall to about 40.8 B. View More Fundamentals

Merck Stock Against Markets

Picking the right benchmark for Merck stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Merck stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Merck is critical whether you are bullish or bearish towards Merck Company at a given time. Please also check how Merck's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Merck without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Price Transformation Now


Price Transformation

Use Price Transformation models to analyze the depth of different equity instruments across global markets
All  Next Launch Module

Merck Corporate Directors

Merck corporate directors refer to members of a Merck board of directors. The board of directors generally takes responsibility for the Merck's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Merck's board members must vote for the resolution. The Merck board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Rochelle LazarusIndependent DirectorProfile
Paul RothmanIndependent DirectorProfile
Mary CoeIndependent DirectorProfile
Patricia RussoIndependent DirectorProfile

How to buy Merck Stock?

Before investing in Merck, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Merck. To buy Merck stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Merck. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Merck stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Merck Company stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Merck Company stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Merck Company, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Merck Stock please use our How to Invest in Merck guide.

Already Invested in Merck Company?

The danger of trading Merck Company is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Merck is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Merck. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Merck Company is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Complementary Tools for Merck Stock analysis

When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Is Merck's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
Dividend Share
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.